IMMvention Therapeutix Inc.
IMMvention develops novel small molecule therapeutics to address unmet needs in hemoglobinopathies (including Sickle Cell Anemia), cardiometabolic, renal and neuroinflammatory diseases caused by dysregulation of multiple pathways.
Company Details
Company type
Year founded
2018
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities
Core capabilities
Potential end market(s)
Products under development
Anti-inflammatory drugs for rare and prevalent inflammation diseases